aTyr Pharma, Inc. Common Stock
$0.38
Market Cap
$37.68M
Shares Outstanding
98.1M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 7, 2015
Round Lot
100
Locale
US
Day Open
$0.40
Day High
$0.40
Day Low
$0.38
Volume
954.2K
VWAP
$0.38
Prev Close
$0.39
Transactions
--
Acc. Volume
--
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
aTyr Pharma, Inc. Common Stock (ATYR) closed the 2026-09-16 session at $0.38, down 1.31% versus the previous close (-0.01). The stock opened at $0.40 and traded between $0.38 and $0.40 during that session. Session trading volume was 954K shares. The volume-weighted average price (VWAP) is $0.38.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
aTyr Pharma, Inc. Common Stock has a market capitalization of $37.7 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. ATYR is listed on the XNAS exchange. The company employs approximately 58 people. aTyr Pharma, Inc. Common Stock is headquartered in SAN DIEGO, CA. The recorded listing date is 2015-05-07.
On this page you can find market ATYR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.